Results 301 to 310 of about 60,909 (346)
Some of the next articles are maybe not open access.

RNA-targeting and gene editing therapies for transthyretin amyloidosis

Nature Reviews Cardiology, 2022
Alberto Aimo   +2 more
exaly   +2 more sources

Transthyretin amyloid cardiomyopathy

Medicina Clínica (English Edition), 2021
Transthyretin (TTR) cardiac amyloidosis is a severe, progressive, infiltrative disease caused by the deposition of TTR at cardiac level. It may be due to a genetic alteration in its hereditary form (ATTRv) or as a consequence of an age-related degenerative process (ATTRwt). Thanks to advances in imaging techniques and the possibility of achieving a non-
Pablo García-Pavía   +2 more
openaire   +3 more sources

A molecular mechanism for transthyretin amyloidogenesis [PDF]

open access: yesNature Communications, 2019
AbstractHuman transthyretin (TTR) is implicated in several fatal forms of amyloidosis. Many mutations of TTR have been identified; most of these are pathogenic, but some offer protective effects. The molecular basis underlying the vastly different fibrillation behaviours of these TTR mutants is poorly understood.
Alycia, Ai Woon Yee   +2 more
exaly   +12 more sources

Wallaby transthyretin

Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 1995
A cDNA library was constructed from liver RNA of the Australian diprotodont marsupial Macropus eugenii, the Tammar wallaby. A cloned full-length transthyretin cDNA was sequenced. The derived amino-acid sequence showed 68% overall similarity to that of human transthyretin, with 86% similarity in the thyroxine binding site.
C M, Brack   +3 more
openaire   +2 more sources

Computational Studies on Transthyretin

Current Medicinal Chemistry, 2012
Among the 23 different fibril proteins described in human amyloidosis, transthyretin is associated with the most common hereditary form of the disease and its knowledge is corroborated through about 150 crystal structures in addition to thousands of small ligands tested as fibril formation inhibitors. In spite of the large amount of available data, the
ORTORE, GABRIELLA MARIA PIA   +1 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy